Shire buys NPS Pharmaceuticals for £3.5bn

Shire is to buy the American biopharmaceutical company NPS Pharmaceuticals for £3.5bn. NPS produces products which are used to treat gastrointestinal disease and endocrine disorders. Shire was paid £1bn by AbbVie in October 2014 following the breakdown of takeover talks between the two.

Leave a Reply

Your email address will not be published. Required fields are marked *